126 related articles for article (PubMed ID: 8915102)
21. Synthesis and calcium channel antagonist activity of 3-arylmethyl 5-isopropyl 1,4-dihydro-2,6-dimethyl-4-(pyridyl)-3,5-pyridinedicarboxylates.
Akula MR; Matowe WC; Wolowyk MW; Knaus EE
Pharm Res; 1990 Sep; 7(9):919-22. PubMed ID: 2235890
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and calcium channel blocker activity of alkyl 1,4-dihydro-2,6-dimethyl-4-nitrobenzyl thioimidazolyl-3,5-pyridinedicarboxylates.
Zarghi A; Faizi M; Abdolahnejad R; Fassihi A
Boll Chim Farm; 2003 May; 142(4):175-9. PubMed ID: 12918227
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of methyl 2-methyl-7,7-dihalo-5-phenyl-2-azabicyclo[4.1.0]hept-3-ene-4-carboxylates with calcium channel antagonist activity.
Mojarrad JS; Miri R; Knaus EE
Bioorg Med Chem; 2004 Jun; 12(12):3215-20. PubMed ID: 15158789
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and calcium channel antagonist activity of nifedipine analogues with methylthioimidazole substituent.
Foroumadi A; Analuie N; Rezvanipour M; Sepehri G; Najafipour H; Sepehri H; Javanmardi K; Esmaeeli F
Farmaco; 2002 Mar; 57(3):195-9. PubMed ID: 11989797
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of 1,4-dihydropyridine calcium channel modulators having a diazen-1-ium-1,2-diolate nitric oxide donor moiety for the potential treatment of congestive heart failure.
Velázquez C; Knaus EE
Bioorg Med Chem; 2004 Jul; 12(14):3831-40. PubMed ID: 15210150
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and calcium channel antagonist activity of alkyl t-butyl esters of nifedipine analogues containing pyridinyl substituents.
Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1987 Dec; 2(2):79-89. PubMed ID: 2855571
[TBL] [Abstract][Full Text] [Related]
27. Enantioselective syntheses and calcium channel modulating effects of (+)- and (-)-3-isopropyl 5-(4-methylphenethyll) 1,4-dihydro-2,6-dimethyl-4-(2-pyridyl)-3,5-pyridinedicarboxylates.
Iqbal N; Vo D; McEwen CA; Wolowyk MW; Knaus EE
Chirality; 1994; 6(7):515-20. PubMed ID: 7986665
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[4-(1-methoxycarbonyl-1,4-dihydropyridyl)]-3 ,5- pyridinedicarboxylates.
Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Arch Pharm (Weinheim); 1999 Nov; 332(11):385-8. PubMed ID: 10605379
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and calcium channel antagonist activity of 1,4-dihydropyridine derivatives containing 4-nitroimidazolyl substituents.
Shafiee A; Rastkary N; Jorjani M
Arzneimittelforschung; 2002; 52(7):537-42. PubMed ID: 12189777
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and calcium channel antagonist activity of 1,2-dihydropyridyl analogues of nifedipine.
Wynn H; Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Nov; 3(3):245-56. PubMed ID: 2855579
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent.
Davood A; Khodarahmi G; Alipour E; Dehpour K; Amini M; Shafiee A
Boll Chim Farm; 2001; 140(6):381-6. PubMed ID: 11822226
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and calcium antagonist activity of new 1,4-dihydropyridines containing nitrobenzylimidazolyl substituent in guinea-pig ileal smooth muscle.
Zarghi A; Derakhshandeh K; Roshanzamir F; Jorjani M; Rastegar H; Varmazyari M; Shafiee A
Boll Chim Farm; 2002; 141(1):15-20. PubMed ID: 12064052
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1,2-dihydropyridyl in place of the 1,4-dihydropyridyl moiety.
Soboleski DA; Li-Kwong-Ken MC; Wynn H; Triggle CR; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Feb; 2(3):177-89. PubMed ID: 2855573
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents.
Navidpour L; Miri R; Shafiee A
Arzneimittelforschung; 2004; 54(9):499-504. PubMed ID: 15500195
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.
Iman M; Davood A; Nematollahi AR; Dehpoor AR; Shafiee A
Arch Pharm Res; 2011 Sep; 34(9):1417-26. PubMed ID: 21975802
[TBL] [Abstract][Full Text] [Related]
38. Syntheses and calcium channel antagonist activity of nifedipine analogues with methylsulfonylimidazolyl substituent.
Shafiee A; Dehpour AR; Hadizadeh F; Azimi M
Pharm Acta Helv; 1998 Jul; 73(2):75-9. PubMed ID: 9700935
[TBL] [Abstract][Full Text] [Related]
39. A symmetrical 1,4-dihydropyridine with opposite actions on K(+)-induced contractions in guinea-pig ileum.
Kaplita PV; Wilkins DE; Adams TC; Hanson RC
Arch Int Pharmacodyn Ther; 1990; 305():25-31. PubMed ID: 1700685
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
